Clinical Trial Update: Emergency Department-Initiated Buprenorphine Validation Network Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating emergency department-initiated buprenorphine for opioid use disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid-use Disorder | Phase 2 | Status: COMPLETED